Perricone MD Acne Relief Maximum Strength Spot Gel

Manufacturer
THG Beauty USA LLC
Effective date
2025-11-07
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:42:30

Label at a glance#

ProductPerricone MD Acne Relief Maximum Strength Spot Gel
Active ingredientSALICYLIC ACID
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

OTC - PURPOSE SECTION

Acne Treatment

INDICATIONS & USAGE SECTION

For the treatment of acne

WARNINGS SECTION

For external use only.

OTC - WHEN USING SECTION

When Using this product skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time.

■ If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

■ Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times

daily if needed or as directed by a doctor.

  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • Sensitivity Test for a New User Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort

occurs, follow the directions stated above.

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, SD Alcohol 40-B, Propanediol, Hamamelis Virginiana (Witch Hazel) Water, Glycerin, Citrulline, Sucrose, Hydroxyethylcellulose, Urea, Alcohol, Polysorbate 20, Panthenol, Sodium Hydroxide, Succinic Acid, Lactic Acid, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Tetrasodium Glutamate Diacetate, Limonene

OTC - QUESTIONS SECTION

1-888-823-7837

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Package Label Principal Display PanelPackage Label Principal Display Panel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN2
346298salicylic acid 0.02 MG/MG Topical GelSCD2
346298salicylic acid 2 % Topical GelSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84448-538-14Perricone MD Acne Relief Maximum Strength Spot Gel1 in 1 CARTONGEL12
84448-538-14Perricone MD Acne Relief Maximum Strength Spot Gel14.1 g in 1 TUBEGEL14.12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84448-53884448-538-14

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Perricone MD Acne Relief Maximum Strength Spot GelSALICYLIC ACIDTHG Beauty USA LLC1f92122d-4873-8c1a-e063-6294a90a1c3b2025-11-07WarningsExact identifier
ndc (package): 84448-538-14
ndc (product): 84448-538
ndc11 (package): 84448053814
spl id: 41d473fb-eac9-8976-e063-6394a90a684b
spl set id: 1f92122d-4873-8c1a-e063-6294a90a1c3b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.